Alpha Healthcare Acquisition Corp. III closes $150M IPO on Nasdaq

Longevity Health Holdings, Inc.

Priced and closed IPO of 15,000,000 units at $10.00 per unit, raising $150M gross.
Simultaneous private placement of 455,000 units to sponsor raised $4.55M.
Net proceeds of $150M deposited into trust account; 24-month deadline for business combination.
Appointed Darlene DeRemer, Eugene Podsiadlo, William Woodward as independent directors.
Company to focus on US healthcare targets for initial business combination.

item 1.01 item 3.02 item 5.02 item 5.03 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

William Woodward

Director

XAGE · Longevity Health Holdings, Inc.

Effective: 2021-07-26
Filed: July 29, 2021, 7:59 PM ET

On July 26, 2021, in connection with the IPO, Darlene T. DeRemer, Eugene L. Podsiadlo and William Woodward (the “New Directors” and, collectively with Rajiv Shukla, the “Directors”) were appointed to the board of directors of the Company (the “Board”).

Appointed

Eugene L. Podsiadlo

Director

XAGE · Longevity Health Holdings, Inc.

Effective: 2021-07-26
Filed: July 29, 2021, 7:59 PM ET

On July 26, 2021, in connection with the IPO, Darlene T. DeRemer, Eugene L. Podsiadlo and William Woodward (the “New Directors” and, collectively with Rajiv Shukla, the “Directors”) were appointed to the board of directors of the Company (the “Board”).

Appointed

Darlene T. DeRemer

Director

XAGE · Longevity Health Holdings, Inc.

Effective: 2021-07-26
Filed: July 29, 2021, 7:59 PM ET

On July 26, 2021, in connection with the IPO, Darlene T. DeRemer, Eugene L. Podsiadlo and William Woodward (the “New Directors” and, collectively with Rajiv Shukla, the “Directors”) were appointed to the board of directors of the Company (the “Board”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William Woodward was appointed as Director at Longevity Health Holdings, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 26, 2021, in connection with the IPO, Darlene T. DeRemer, Eugene L. Podsiadlo and William Woodward (the “New Directors” and, collectively with Rajiv Shukla, the “Directors”) were appointed to the board of directors of the Company (the “Board”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Eugene L. Podsiadlo was appointed as Director at Longevity Health Holdings, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 26, 2021, in connection with the IPO, Darlene T. DeRemer, Eugene L. Podsiadlo and William Woodward (the “New Directors” and, collectively with Rajiv Shukla, the “Directors”) were appointed to the board of directors of the Company (the “Board”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Darlene T. DeRemer was appointed as Director at Longevity Health Holdings, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 26, 2021, in connection with the IPO, Darlene T. DeRemer, Eugene L. Podsiadlo and William Woodward (the “New Directors” and, collectively with Rajiv Shukla, the “Directors”) were appointed to the board of directors of the Company (the “Board”).

View on SEC.gov

Longevity Health Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-21-039290

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.